What is WIPO ST.25 and how does it relate to patent applications?

WIPO ST.25 is a standard for the presentation of nucleotide and amino acid sequence listings in patent applications. It was used for applications filed before July 1, 2022. The MPEP notes:

“This section is not applicable to applications filed on or after July 1, 2022, having disclosures of nucleotide and/or amino acid sequences as defined in 37 CFR 1.831(b).”

For applications filed on or after July 1, 2022, the newer WIPO ST.26 standard applies, as outlined in MPEP §§ 2412 – 2419.

To learn more:

Topics: MPEP 2400 - Biotechnology, MPEP 2431 - Sample "Sequence Listing" Under Wipo St.25, Patent Law, Patent Procedure
Tags: biotechnology patents, patent applications, sequence listing, wipo st.25